Ovintiv price target raised to $52 from $51 at UBS

UBS raised the firm’s price target on Ovintiv (OVV) to $52 from $51 and keeps a Buy rating on the shares. Persistent commodity headwinds continue to dampen upside potential, the analyst tells investors in a research note.